Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
36.59
+1.75 (5.02%)
At close: Jun 26, 2026, 4:00 PM EDT
37.32
+0.73 (2.00%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Collegium Pharmaceutical Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Collegium Pharmaceutical stock have an average target of 53.4, with a low estimate of 44 and a high estimate of 60. The average target predicts an increase of 45.94% from the current stock price of 36.59.
Analyst Consensus: Buy
* Price targets were last updated on May 13, 2026.
Analyst Ratings
The average analyst rating for Collegium Pharmaceutical stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| Barclays | Barclays | Buy Reiterates $56 | Buy | Reiterates | $56 | +53.05% | May 13, 2026 |
| Needham | Needham | Buy Maintains $56 | Buy | Maintains | $56 | +53.05% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +63.98% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $44 | Hold | Maintains | $44 | +20.25% | Apr 23, 2026 |
Financial Forecast
Revenue This Year
874.57M
from 780.57M
Increased by 12.04%
Revenue Next Year
885.86M
from 874.57M
Increased by 1.29%
EPS This Year
7.72
from 7.42
Increased by 4.04%
EPS Next Year
7.61
from 7.72
Decreased by -1.40%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 882.6M | 994.0M | |
| Avg | 874.6M | 885.9M | |
| Low | 861.3M | 756.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.1% | 13.7% | |
| Avg | 12.0% | 1.3% | |
| Low | 10.3% | -13.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 7.72 | 7.61 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 4.0% | -1.4% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.